Teplizumab [Meta Analysis] Narrative Review of Anti-CD3 Antibody and Anti-CD20 Antibody: Immunotherapeutic Strategies to Treat and Prevent Type 1 Diabetes Dr. Shivani Desai November 23, 2022
![[Meta Analysis] Narrative Review of Anti-CD3 Antibody and Anti-CD20 Antibody: Immunotherapeutic Strategies to Treat and Prevent Type 1 Diabetes](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhsiJWDvJoKDWi75rnVgLAkD5mMaSCvAV2aRi2gNHfJOROxaVOCbGeeDY4J_OPlw3UQaUbnwIY5RnfnaOZOZaDcvt3AmC05t3IblT-hrKdhuda4R8xEjdSjLUW4GwUdS1jNFhOhzspwrTXn0QePbDDUcnE9gBMuH8DHHMbbY1CwmPMwWytGcktKJcT_bg/w74-h74-p-k-no-nu/Screenshot%202022-11-24%20at%208.35.00%20AM.png)
